Skip to main content
SpringerLink
Log in

Response: Physostigmine May Not Be the Only Option for Treating Anticholinergic Syndrome

  • The Poison Pen
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Walker A, Delle Donne A, Douglas E, Spicer K, Pluim T. Novel use of dexmedetomidine for the treatment of anticholinergic toxidrome. J Med Toxicol Off J Am Coll Med Toxicol. 2014.

  2. Moore PW RJ, Donovan JW. Physostigmine is the antidote for anticholinergic syndrome. J Med Toxicol. 2014

  3. Dart RC, Borron SW, Caravati EM et al (2009) Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med 54(3):386–394, e381

    Article  PubMed  Google Scholar 

  4. Frascogna N (2007) Physostigmine: is there a role for this antidote in pediatric poisonings? Curr Opin Pediatr 19(2):201–205

    Article  PubMed  Google Scholar 

  5. Stilson M, Kelly K, Suchard J (2001) Physostigmine as an antidote. Calif J Emerg Med Calif Chapter Am Acad Emerg Med 2(4):47–48

    CAS  Google Scholar 

  6. Suchard JR (2003) Assessing physostigmine’s contraindication in cyclic antidepressant ingestions. J Emerg Med 25(2):185–191

    Article  PubMed  Google Scholar 

Download references

Disclaimer:

The views expressed in this article are those of the author and do not reflect the official policy or position of the Department of the Navy, Department of Defense, nor the US Government.

This work was prepared as part of the author’s official duties. Title 17 U.S.C. 105 provides that “Copyright protection under this title is not available for any work of the US Government.” Title 17 U.S.C. 101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person’s official duties.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, VA, USA

    Thomas Pluim

Authors
  1. Thomas Pluim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Pluim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pluim, T. Response: Physostigmine May Not Be the Only Option for Treating Anticholinergic Syndrome. J. Med. Toxicol. 11, 161–162 (2015). https://doi.org/10.1007/s13181-014-0443-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-014-0443-y

Keywords

Search

Navigation